These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 9308767)
21. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells. Jiang X; Zhu S; Panetti TS; Bromberg ME Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547 [TBL] [Abstract][Full Text] [Related]
22. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. Zhang E; St Charles R; Tulinsky A J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787 [TBL] [Abstract][Full Text] [Related]
23. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184 [TBL] [Abstract][Full Text] [Related]
24. [The role of tissue factor and its inhibitor in hemostasis]. Naumnik B; Małyszko J; Myśliwiec M Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646 [TBL] [Abstract][Full Text] [Related]
25. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor. Lindhout T; Franssen J; Willems G Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320 [TBL] [Abstract][Full Text] [Related]
26. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy. Freskgård PO; Olsen OH; Persson E Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844 [TBL] [Abstract][Full Text] [Related]
27. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609 [TBL] [Abstract][Full Text] [Related]
28. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation. Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025 [TBL] [Abstract][Full Text] [Related]
29. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor. Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921 [TBL] [Abstract][Full Text] [Related]
30. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162 [TBL] [Abstract][Full Text] [Related]
32. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Siegbahn A; Johnell M; Rorsman C; Ezban M; Heldin CH; Rönnstrand L Blood; 2000 Nov; 96(10):3452-8. PubMed ID: 11071641 [TBL] [Abstract][Full Text] [Related]
33. Catabolism of factor VIIa bound to tissue factor in fibroblasts in the presence and absence of tissue factor pathway inhibitor. Iakhiaev A; Pendurthi UR; Voigt J; Ezban M; Vijaya Mohan Rao L J Biol Chem; 1999 Dec; 274(52):36995-7003. PubMed ID: 10601255 [TBL] [Abstract][Full Text] [Related]
34. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719 [TBL] [Abstract][Full Text] [Related]
35. Two independent binding sites on monolayers of human endothelial cells are responsible for interaction with coagulation factor VII and factor VIIa. Reuning U; Preissner KT; Müller-Berghaus G Thromb Haemost; 1993 Feb; 69(2):197-204. PubMed ID: 8456434 [TBL] [Abstract][Full Text] [Related]
36. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214 [TBL] [Abstract][Full Text] [Related]
37. Progesterone utilizes distinct membrane pools of tissue factor to increase coagulation and invasion and these effects are inhibited by TFPI. Henriquez S; Calderon C; Quezada M; Oliva B; Bravo ML; Aranda E; Kato S; Cuello MA; Gutiérrez J; Quest AF; Owen GI J Cell Physiol; 2011 Dec; 226(12):3278-85. PubMed ID: 21344386 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs. Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770 [TBL] [Abstract][Full Text] [Related]
39. Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat. Han X; Girard TJ; Baum P; Abendschein DR; Broze GJ Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2563-7. PubMed ID: 10521388 [TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]